Most significant reduction of cardiovascular events in patients undergoing lipoproteinapheresis due to raised Lp(a) levels – A multicenter observational study-Reference-Cited by-同舟云学术

Most significant reduction of cardiovascular events in patients undergoing lipoproteinapheresis due to raised Lp(a) levels – A multicenter observational study

Published:2017-11 Issue: Volume:30 Page:246-252
ISSN:1567-5688
Container-title:Atherosclerosis Supplements
language:en
Short-container-title:Atherosclerosis Supplements

Author:

Schatz U.,Tselmin S.,Müller G.,Julius U.,Hohenstein B.,Fischer S.,Bornstein S.R.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,General Medicine,Internal Medicine

Reference17 articles.

1. Lipoprotein(a): a risk factor for atherosclerosis;Fischer;Dtsch Med Wochenschr,2014

2. Lipoprotein apheresis for lipoprotein(a)-associated cardiovascular disease: prospective 5 Years of follow-up and apolipoprotein(a) characterization;Roeseler;Arterioscler Thromb Vasc Biol,2016

3. Current view: indications for extracorporeal lipid apheresis treatment;Schettler;Clin Res Cardiol Suppl,2012

4. Why an apheresis center should offer more than one lipoprotein apheresis method;Julius;Ther Apher Dial,2013

5. Lipoproteinapheresis: an update;Julius;Clin Lipidol,2013

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mitochondrial related variants associated with cardiovascular traits;Frontiers in Physiology;2024-08-27

2. Long-term lipoprotein apheresis reduces cardiovascular events in high-risk patients with isolated lipoprotein(a) elevation;Journal of Clinical Lipidology;2024-04

3. Lipoprotein Apheresis: Current Recommendations for Treating Familial Hypercholesterolemia and Elevated Lipoprotein(a);Current Atherosclerosis Reports;2023-06-05

4. Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Ninth Special Issue;Journal of Clinical Apheresis;2023-04

5. State of the Art: Lipoproteinapherese;DMW - Deutsche Medizinische Wochenschrift;2023-03-29